One patient in our cohort had a hepatocellular carcinoma at the time the AMACR deficiency diagnosis was established and one (unreported) sibling of another patient who died of liver cancer was not evaluated for AMACR deficiency. Here, AMACR is linked to hepatocellular carcinoma.